Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$2.58 - $3.91 $35,487 - $53,782
-13,755 Closed
0 $0
Q3 2021

Nov 16, 2021

SELL
$2.77 - $4.05 $276,446 - $404,190
-99,800 Reduced 87.89%
13,755 $47,000
Q2 2021

Aug 10, 2021

SELL
$1.71 - $4.14 $5,985 - $14,489
-3,500 Reduced 2.99%
113,555 $437,000
Q1 2021

May 13, 2021

BUY
$0.85 - $5.27 $99,496 - $616,879
117,055 New
117,055 $310,000
Q2 2019

Aug 05, 2019

SELL
$1.81 - $2.45 $40,363 - $54,635
-22,300 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$2.3 - $3.27 $5,750 - $8,175
-2,500 Reduced 10.08%
22,300 $55,000
Q3 2018

Nov 08, 2018

BUY
$3.4 - $4.84 $13,940 - $19,844
4,100 Added 19.81%
24,800 $119,000
Q2 2018

Oct 05, 2018

BUY
$3.03 - $4.98 $29,693 - $48,804
9,800 Added 89.91%
20,700 $86,000
Q1 2018

May 15, 2018

BUY
$2.48 - $3.21 $27,032 - $34,989
10,900 New
10,900 $33,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $182M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.